Evidence map›Paper›PMID 39301259›Full record

ReviewExperimental and therapeutic medicine2024

Atypical pneumonia (Review).

Vasiliki Epameinondas Georgakopoulou, Ioannis G Lempesis, Kyriakos Tarantinos, Pagona Sklapani, Nikolaos Trakas, Demetrios A Spandidos

Abstract readReview
In one paragraph

Review in Experimental and therapeutic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Implications of empirical testing and treatment for atypical bacteria in patients hospitalized with COVID, influenza, or RSV: a retrospective observational cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Observational
  3. Article
  4. Review
  5. Frontiers in cellular and infection microbiology · 2026
    Review
  6. Article
  7. Article
  8. Clinical Features of 186 Cases ofInfection and drug resistance · 2026
    Article
  9. Infection and drug resistance · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. An Atypical Pneumonia Case of Quinolone-RefractoryInfection and drug resistance · 2025
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vasiliki Epameinondas GeorgakopoulouDepartment of Pathophysiology, Laiko General Hospital, Medical School of National and Kapodistrian University of Athens, 11527 Athens, Greece.
Ioannis G LempesisDepartment of Pathophysiology, Laiko General Hospital, Medical School of National and Kapodistrian University of Athens, 11527 Athens, Greece.
Kyriakos TarantinosFirst Department of Respiratory Medicine, Sismanogleio Hospital, 15126 Athens, Greece.
Pagona SklapaniDepartment of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece.
Nikolaos TrakasDepartment of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece.
Demetrios A SpandidosLaboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atypical pneumonia encompasses diverse pathogens, such as

Indexed as

atypical pneumoniaChlamydia pneumoniaeLegionellaMycoplasma pneumoniaerespiratory infection

Identifiers

PMID39301259
PMCPMC11412103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.